1. Holm AM, Riise GC, Brinch L, Bjørtuft O, Iversen M, Simonsen S, et al. Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: unresolved questions. Transplantation. 2013; 96:e21–2.
2. Kim YR, Haam SJ, Park YG, Lim BJ, Park YM, Paik HC. Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. Yonsei Med J. 2012; 53:1054–7.
Article
3. Soubani AO, Kingah P, Alshabani K, Muma G, Haq A. Lung transplantation following hematopoietic stem cell transplantation: report of two cases and systematic review of literature. Clin Transplant. 2014; 28:776–82.
Article
4. Orens JB, Estenne M, Arcasoy S, Conte JV, Corris P, Egan JJ, et al. International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung transplant. 2006; 25:745–55.
Article
5. Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis. 2006; 42:692–9.
Article
6. Nunley DR, Bauldoff GS, Mangino JE, Pope-Harman AL. Mortality associated with Acinetobacter baumannii infections experienced by lung transplant recipients. Lung. 2010; 188:381–5.
Article
7. Shields RK, Kwak EJ, Potoski BA, Doi Y, Adams-Haduch JM, Silviera FP, et al. High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen. Diagn Microbiol Infect Dis. 2011; 70:246–52.
Article
8. Shoham S, Shah PD. Impact of multidrug-resistant organisms on patients considered for lung transplantation. Infect Dis Clin North Am. 2013; 27:343–58.
Article
9. Bonvillain RW, Valentine VG, Lombard G, LaPlace S, Dhillon G, Wang G. Post-operative infections in cystic fibrosis and non-cystic fibrosis patients after lung transplantation. J Heart Lung transplant. 2007; 26:890–7.
Article
10. Palmer SM, Alexander BD, Sanders LL, Edwards LJ, Reller LB, Davis RD, et al. Significance of blood stream infection after lung transplantation: analysis in 176 consecutive patients. Transplantation. 2000; 69:2360–6.
11. Vos R, Vanaudenaerde BM, Geudens N, Dupont LJ, Van Raemdonck DE, Verleden GM. Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation? Eur Respir J. 2008; 31:1037–45.
Article
12. Murray S, Charbeneau J, Marshall BC, LiPuma JJ. Impact of burkholderia infection on lung transplantation in cystic fibrosis. Am J Respir Crit Care Med. 2008; 178:363–71.
13. Kennedy MP, Coakley RD, Donaldson SH, Aris RM, Hohneker K, Wedd JP, et al. Burkholderia gladioli: five year experience in a cystic fibrosis and lung transplantation center. J Cyst Fibros. 2007; 6:267–73.
Article
14. Sopirala MM, Pope-Harman A, Nunley DR, Moffatt- Bruce S, Ross P, Martin SI. Multidrug-resistant Acinetobacter baumannii pneumonia in lung transplant recipients. J Heart Lung Transplant. 2008; 27:804–7.
Article
15. Martins N, Martins IS, de Freitas WV, de Matos JA, Magalhães AC, Girão VB, et al. Severe infection in a lung transplant recipient caused by donor-transmitted carbapenem-resistant Acinetobacter baumannii. Transpl Infect Dis. 2012; 14:316–20.
Article
16. Michalopoulos A, Falagas ME. Treatment of Acinetobacter infections. Expert Opin Pharmacother. 2010; 11:779–88.
17. Petrosillo N, Ioannidou E, Falagas ME. Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies. Clin Microbiol Infect. 2008; 14:816–27.
Article
18. Gordon NC, Wareham DW. A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline. J Antimicrob Chemother. 2009; 63:775–80.
Article
19. Gallagher JC, Rouse HM. Tigecycline for the treatment of Acinetobacter infections: a case series. Ann Pharmacother. 2008; 42:1188–94.
Article
20. Falagas ME, Kasiakou SK. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care. 2006; 10:R27.